إعلان
إعلان

NVAX

NVAX logo

Novavax Inc

7.44
USD
برعاية
+0.18
+2.55%
٠٦ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

قبل الإفتتاح

7.45

0.00
+0.07%

تقارير أرباح NVAX

النسبة الإيجابية المفاجئة

NVAX تفوق 17 من 40 آخر التقديرات.

43%

التقرير التالي

بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$80.88M
/
-$0.49
التغير الضمني من Q3 25 (Revenue/ EPS)
+14.81%
/
-60.80%
التغير الضمني من Q4 24 (Revenue/ EPS)
-8.41%
/
-40.96%

Novavax Inc earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, NVAX reported earnings of -1.25 USD per share (EPS) for Q3 25, missing the estimate of -1.21 USD, resulting in a -3.31% surprise. Revenue reached 70.44 مليون, compared to an expected 42.98 مليون, with a 63.92% difference. The market reacted with a -1.30% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of -0.49 USD, with revenue projected to reach 80.88 مليون USD, implying an نقصان of -60.80% EPS, and زيادة of 14.81% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Novavax Inc reported EPS of -$1.25, missing estimates by -3.31%, and revenue of $70.44M, 63.92% above expectations.
The stock price moved down -1.3%, changed from $7.69 before the earnings release to $7.59 the day after.
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
Based on 10 المحللين, Novavax Inc is expected to report EPS of -$0.49 and revenue of $80.88M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان